查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1671061

中枢神经系统药物市场、规模、占有率、趋势、行业分析报告（依疾病、药物类别、通路和地区）- 市场预测2025-2034

Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease, Drug Class, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球中枢神经系统药物市场预计到2034年将达到 3,812.7亿美元。本研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

中枢神经系统（CNS）治疗市场包括治疗阿兹海默症、帕金森氏症、癫痫和忧郁症等神经系统疾病的药物和治疗，重点是改善大脑和脊髓的健康和功能。

由于脑肿瘤和神经胶质瘤等中枢神经系统癌症的发生率不断增加，中枢神经系统（CNS）药物市场日益扩大。诊断数量的增加推动了对有效治疗的需求。例如，美国脑瘤协会报告指出，美国每年有 9万人被诊断出患有原发性脑瘤，病例呈现成长趋势。此外，老化也是中枢神经系统癌症增加的原因之一，因为老年人更容易受到致癌辐射的影响。

中枢神经系统（CNS）药物市场的成长受到政府在医疗保健方面支出增加的推动。政府和私营部门都在增加对医疗保健的投资，更加重视开发针对忧郁症、焦虑症和阿兹海默症等中枢神经系统疾病的有效治疗方法。例如，根据世界银行集团的资料，2021年医疗保健支出占GDP总量的10.3%。这些资金支持促进了研究和创新，推出了具有成本效益的治疗方法。

由于先进的诊断技术使得识别神经系统疾病变得更加容易，中枢神经系统药物市场蓬勃发展。这些进步使得诊断更加早期、更准确，增加了对有效治疗的需求。

中枢神经系统治疗市场报告重点

根据药物类别，由于注意力不足过动症（ADHD）和睡眠障碍的盛行率不断上升，中枢神经系统兴奋剂领域预计将出现显着成长，在全球市场上呈现高年复合成长率。

依通路划分，由于因阿兹海默症和帕金森氏症等神经退化性疾病住院患者数量增加，医院药房部门在2024年占据了中枢神经系统药物市场的主导地位。

在2024年的中枢神经系统药物市场中，由于阿兹海默症患者病率的上升，北美占据了最大的收入占有率。

由于製药业的扩张，印度中枢神经系统药物市场预计将大幅成长。

全球市场的一些主要参与者包括Biogen、Otsuka Pharmaceutical Co., Ltd.、Eli Lilly and Company、Merck & Co., Inc.、Astra Zeneca、Takeda Pharmaceutical Company Limited、Novartis AG、Teva Pharmaceutical Industries Ltd、Johnson & Johnson, Inc.、Pfizer Inc. 。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球中枢神经系统药物市场洞察

  • 市场概况
  • 中枢神经系统药物市场动态
    • 驱动因素和机会
      • 老年人口增加将推动市场成长
      • 对心理健康的投资增加推动市场规模扩大
    • 阻碍因素和挑战
      • 监理障碍
  • PESTEL 分析
  • 中枢神经系统药物的市场趋势
  • 价值链分析
  • COVID-19 影响分析

第5章 全球中枢神经系统药物市场（依疾病类型）

  • 主要调查结果
  • 简介
  • 神经血管疾病
  • 中枢神经系统创伤
  • 心理健康
  • 神经退化性疾病
  • 传染病
  • 中枢神经系统癌症
  • 其他

第6章 全球中枢神经系统药物市场（依药物类别）

  • 主要调查结果
  • 简介
  • 麻醉药物
  • 抗惊厥药
  • 止吐药
  • 中枢神经系统兴奋剂
  • 止痛药
  • 其他

第7章 全球中枢神经系统药物市场（依通路）

  • 主要调查结果
  • 简介
  • 医院药房
  • 零售药局
  • 其他

第8章 全球中枢神经系统治疗市场（依地区）

  • 主要调查结果
  • 简介
    • 中枢神经系统治疗市场评估：地区，2020年至2034年
  • 北美洲
    • 依疾病类型，2020年至2034年
    • 依药物类别，2020年至2034年
    • 依通路，2020年至2034年
    • 美国
    • 加拿大
  • 欧洲
    • 依疾病类型，2020年至2034年
    • 依药物类别，2020年至2034年
    • 依通路，2020年至2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 依疾病类型，2020年至2034年
    • 依药物类别，2020年至2034年
    • 依通路，2020年至2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 依疾病类型，2020年至2034年
    • 依药物类别，2020年至2034年
    • 依通路，2020年至2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 依疾病类型，2020年至2034年
    • 依药物类别，2020年至2034年
    • 依通路，2020年至2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第9章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/公开

第10章 公司简介

  • Biogen
  • Otsuka Pharmaceutical Co., Ltd.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Astra Zeneca
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson, Inc.
  • Pfizer Inc.
Product Code: PM5368

The global central nervous system therapeutics market size is expected to reach USD 381.27 billion by 2034, according to a new study by Polaris Market Research. The report "Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease, Drug Class, Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The central nervous system (CNS) therapeutics market encompasses drugs and treatments for neurological disorders like Alzheimer's, Parkinson's, epilepsy, and depression, focusing on improving brain and spinal cord health and function.

The central nervous system (CNS) therapeutics market is expanding due to the growing incidence of CNS cancers, including brain tumors, gliomas, and other types. The increasing number of diagnoses is driving demand for effective treatments. For example, the American Brain Tumor Association reports that 90,000 people in the US are diagnosed with a primary brain tumor each year, reflecting a rising trend in cases. Additionally, the aging population is contributing to the increase in CNS cancer cases, as older adults are more vulnerable to cancer-causing radiation.

The central nervous system (CNS) therapeutics market growth is being driven by increased government spending on healthcare. Both governments and private sectors are investing more in healthcare, which has led to a stronger focus on developing effective treatments for CNS disorders such as depression, anxiety, and Alzheimer's disease. For example, healthcare expenditure in 2021 accounted for 10.3% of total GDP, according to the World Bank Group. This financial support has fostered research and innovation, resulting in the introduction of cost-effective therapies.

The central nervous system therapeutics market is growing due to advanced diagnostic technologies that make it easier to identify neurological disorders. These advancements lead to earlier and more accurate diagnoses and lead to an increased demand for effective treatments.

Central Nervous System Therapeutics Market Report Highlights

Based on drug class, the CNS stimulants segment is expected to experience significant growth with a high CAGR in the global market due to the rising prevalence of attention deficit hyperactivity (ADHD) and sleep disorders.

By distribution channel, the hospital pharmacies segment dominated the central nervous system therapeutics market in 2024 due to the rising number of hospital admissions for neurodegenerative diseases, such as Alzheimer's and Parkinson's.

In 2024, North America had the largest revenue share in the central nervous system therapeutics market due to the rising prevalence of Alzheimer's disease.

The central nervous system therapeutics market in India is projected for substantial growth, driven by the growth of the pharmaceutical industry.

A few of the global key market players are Biogen; Otsuka Pharmaceutical Co., Ltd.; Eli Lilly and Company; Merck & Co., Inc.; Astra Zeneca; Takeda Pharmaceutical Company Limited; Novartis AG; Teva Pharmaceutical Industries Ltd; Johnson & Johnson, Inc.; and Pfizer Inc.

Polaris market research has segmented the central nervous system therapeutics market report on the basis of disease, drug class, distribution channel, and region:

By Disease Outlook (Revenue - USD Billion, 2020-2034)

  • § Neurovascular Diseases
  • § CNS Trauma
  • § Mental Health
  • § Neurodegenerative Diseases
  • § Alzheimer's Disease
  • § Parkinson's Disease
  • § Multiple Sclerosis
  • § Huntington's Disease
  • § Amyotrophic Lateral Sclerosis
  • § Others
  • § Infectious Diseases
  • § CNS Cancer
  • § Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

  • § Anesthetics
  • § Anticonvulsants
  • § Antiemetics
  • § CNS Stimulants
  • § Pain Relievers
  • § Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • § Hospital Pharmacies
  • § Retail Pharmacies
  • § Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Central Nervous System Therapeutics Market Insights

  • 4.1. Central Nervous System Therapeutics Market - Market Snapshot
  • 4.2. Central Nervous System Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population is Driving Market Growth
      • 4.2.1.2. Increase in Investment in Mental Health is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Hurdle
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Central Nervous System Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Central Nervous System Therapeutics Market, by Disease

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • 5.3. Neurovascular Disease
    • 5.3.1. Global Central Nervous System Therapeutics Market, by Neurovascular Disease, by Region, 2020-2034 (USD million)
  • 5.4. CNS Trauma
    • 5.4.1. Global Central Nervous System Therapeutics Market, by CNS Trauma, by Region, 2020-2034 (USD million)
  • 5.5. Mental Health
    • 5.5.1. Global Central Nervous System Therapeutics Market, by Mental Health, by Region, 2020-2034 (USD million)
  • 5.6. Neurodegenerative Diseases
    • 5.6.1. Global Central Nervous System Therapeutics Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD million)
    • 5.6.2. Alzheimer's Disease
      • 5.6.2.1. Global Central Nervous System Therapeutics Market, by Alzheimer's Disease, by Region, 2020-2034 (USD million)
    • 5.6.3. Parkinsosn's Disease
      • 5.6.3.1. Global Central Nervous System Therapeutics Market, by Parkinsosn's Disease, by Region, 2020-2034 (USD million)
    • 5.6.4. Multiple Sclerosis
      • 5.6.4.1. Global Central Nervous System Therapeutics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
    • 5.6.5. Huntington's Disease
      • 5.6.5.1. Global Central Nervous System Therapeutics Market, by Huntington's Disease, by Region, 2020-2034 (USD million)
    • 5.6.6. Amytrophic Lateral Sclerosis
      • 5.6.6.1. Global Central Nervous System Therapeutics Market, by Amytrophic Lateral Sclerosis, by Region, 2020-2034 (USD million)
    • 5.6.7. Others
      • 5.6.7.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)
  • 5.7. Infectious Diseases
    • 5.7.1. Global Central Nervous System Therapeutics Market, by Infectious Diseases, by Region, 2020-2034 (USD million)
  • 5.8. CNS Cancer
    • 5.8.1. Global Central Nervous System Therapeutics Market, by CNS Cancer, by Region, 2020-2034 (USD million)
  • 5.9. Others
    • 5.9.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

6. Global Central Nervous System Therapeutics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • 6.3. Anesthetics
    • 6.3.1. Global Central Nervous System Therapeutics Market, by Anesthetics, by Region, 2020-2034 (USD million)
  • 6.4. Anticonvulsants
    • 6.4.1. Global Central Nervous System Therapeutics Market, by Anticonvulsants, by Region, 2020-2034 (USD million)
  • 6.5. Antiemetics
    • 6.5.1. Global Central Nervous System Therapeutics Market, by Antiemetics, by Region, 2020-2034 (USD million)
  • 6.6. CNS Stimulants
    • 6.6.1. Global Central Nervous System Therapeutics Market, by CNS Stimulants, by Region, 2020-2034 (USD million)
  • 6.7. Pain Relievers
    • 6.7.1. Global Central Nervous System Therapeutics Market, by Pain Relievers, by Region, 2020-2034 (USD million)
  • 6.8. Others
    • 6.8.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Central Nervous System Therapeutics Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Central Nervous System Therapeutics Market, by Hospital Pharmacies, by Region, 2020-2034 (USD million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Central Nervous System Therapeutics Market, by Retail Pharmacies, by Region, 2020-2034 (USD million)
  • 7.5. Others
    • 7.5.1. Global Central Nervous System Therapeutics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Central Nervous System Therapeutics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Central Nervous System Therapeutics Market Assessment, By Geography, 2020-2034 (USD million)
  • 8.3. Central Nervous System Therapeutics Market - North America
    • 8.3.1. North America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.3.2. North America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.3.3. North America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.3.4. Central Nervous System Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.3.4.2. U.S.: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.3.4.3. U.S.: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.3.5. Central Nervous System Therapeutics Market - Canada
      • 8.3.5.1. Canada: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.3.5.2. Canada: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.3.5.3. Canada: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.4. Central Nervous System Therapeutics Market - Europe
    • 8.4.1. Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.4.2. Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.4.3. Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.4. Central Nervous System Therapeutics Market - UK
      • 8.4.4.1. UK: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.4.2. UK: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.4.3. UK: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.5. Central Nervous System Therapeutics Market - France
      • 8.4.5.1. France: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.5.2. France: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.5.3. France: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.6. Central Nervous System Therapeutics Market - Germany
      • 8.4.6.1. Germany: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.6.2. Germany: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.6.3. Germany: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.7. Central Nervous System Therapeutics Market - Italy
      • 8.4.7.1. Italy: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.7.2. Italy: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.7.3. Italy: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.8. Central Nervous System Therapeutics Market - Spain
      • 8.4.8.1. Spain: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.8.2. Spain: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.8.3. Spain: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.9. Central Nervous System Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.9.2. Netherlands: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.9.3. Netherlands: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.10. Central Nervous System Therapeutics Market - Russia
      • 8.4.10.1. Russia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.10.2. Russia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.10.3. Russia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.4.11. Central Nervous System Therapeutics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.4.11.2. Rest of Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.4.11.3. Rest of Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.5. Central Nervous System Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.5.2. Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.5.3. Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.4. Central Nervous System Therapeutics Market - China
      • 8.5.4.1. China: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.4.2. China: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.4.3. China: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.5. Central Nervous System Therapeutics Market - India
      • 8.5.5.1. India: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.5.2. India: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.5.3. India: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.6. Central Nervous System Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.6.2. Malaysia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.6.3. Malaysia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.7. Central Nervous System Therapeutics Market - Japan
      • 8.5.7.1. Japan: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.7.2. Japan: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.7.3. Japan: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.8. Central Nervous System Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.8.2. Indonesia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.8.3. Indonesia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.9. Central Nervous System Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.9.2. South Korea: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.9.3. South Korea: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.10. Central Nervous System Therapeutics Market - Australia
      • 8.5.10.1. Australia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.10.2. Australia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.10.3. Australia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.5.11. Central Nervous System Therapeutics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.6. Central Nervous System Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.6.2. Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.6.3. Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.4. Central Nervous System Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.4.2. Saudi Arabia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.4.3. Saudi Arabia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.5. Central Nervous System Therapeutics Market - UAE
      • 8.6.5.1. UAE: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.5.2. UAE: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.5.3. UAE: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.6. Central Nervous System Therapeutics Market - Israel
      • 8.6.6.1. Israel: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.6.2. Israel: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.6.3. Israel: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.7. Central Nervous System Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.7.2. South Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.7.3. South Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.6.8. Central Nervous System Therapeutics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • 8.7. Central Nervous System Therapeutics Market - Latin America
    • 8.7.1. Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
    • 8.7.2. Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
    • 8.7.3. Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.4. Central Nervous System Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.4.2. Mexico: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.4.3. Mexico: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.5. Central Nervous System Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.5.2. Brazil: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.5.3. Brazil: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.6. Central Nervous System Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.6.2. Argentina: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.6.3. Argentina: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
    • 8.7.7. Central Nervous System Therapeutics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
      • 8.7.7.2. Rest of Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
      • 8.7.7.3. Rest of Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Otsuka Pharmaceutical Co., Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Eli Lilly and Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merck & Co., Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Astra Zeneca
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takeda Pharmaceutical Company Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teva Pharmaceutical Industries Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Johnson & Johnson, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 2 Global Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 3 Global Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 4 North America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 5 North America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 6 North America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 7 U.S.: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 8 U.S.: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 9 U.S.: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 10 Canada: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 11 Canada: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 12 Canada: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 13 Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 14 Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 15 Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 16 UK: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 17 UK: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 18 UK: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 19 France: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 20 France: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 21 France: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 22 Germany: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 23 Germany: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 24 Germany: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 25 Italy: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 26 Italy: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 27 Italy: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 28 Spain: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 29 Spain: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 30 Spain: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 31 Netherlands: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 32 Netherlands: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 33 Netherlands: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 34 Russia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 35 Russia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 36 Russia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 37 Rest of Europe: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 38 Rest of Europe: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 39 Rest of Europe: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 40 Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 41 Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 42 Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 43 China: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 44 China: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 45 China: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 46 India: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 47 India: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 48 India: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 49 Malaysia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 50 Malaysia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 51 Malaysia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 52 Japan: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 53 Japan: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 54 Japan: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 55 Indonesia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 56 Indonesia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 57 Indonesia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 58 South Korea: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 59 South Korea: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 60 South Korea: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 61 Australia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 62 Australia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 63 Australia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 64 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 65 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 66 Rest of Asia Pacific: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 67 Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 68 Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 69 Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 70 Saudi Arabia: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 71 Saudi Arabia: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 72 Saudi Arabia: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 73 UAE: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 74 UAE: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 75 UAE: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 76 Israel: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 77 Israel: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 78 Israel: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 79 South Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 80 South Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 81 South Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 82 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 83 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 84 Rest of Middle East & Africa: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 85 Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 86 Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 87 Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 88 Mexico: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 89 Mexico: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 90 Mexico: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 91 Brazil: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 92 Brazil: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 93 Brazil: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 94 Argentina: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 95 Argentina: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 96 Argentina: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)
  • Table 97 Rest of Latin America: Central Nervous System Therapeutics Market, by Disease, 2020-2034 (USD million)
  • Table 98 Rest of Latin America: Central Nervous System Therapeutics Market, by Drug Class, 2020-2034 (USD million)
  • Table 99 Rest of Latin America: Central Nervous System Therapeutics Market, by Distribution Channel, 2020-2034 (USD million)

List of Figures:

  • Figure 1. Global Central Nervous System Therapeutics Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Disease
  • Figure 7. Global Central Nervous System Therapeutics Market, by Disease, 2024 & 2034 (USD million)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Central Nervous System Therapeutics Market, by Drug Class, 2024 & 2034 (USD million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Central Nervous System Therapeutics Market, by Distribution Channel, 2024 & 2034 (USD million)
  • Figure 12. Global Central Nervous System Therapeutics Market Assessment, By Geography, 2020-2034 (USD million)
  • Figure 13. Strategic Analysis - Global Central Nervous System Therapeutics Market